Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maret

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Biochemistry|June 15, 1983
Substrate specificity of the human splenic non-specific soluble beta-glucosidaseA Maret, R Salvayre, A Negre, et al.
Progress in Clinical and Biological Research|January 1, 1982
Comparative properties of the three groups of splenic beta-glucosidase molecular formsR Salvayre, A Maret, A Negre, et al.
The Biochemical Journal|May 7, 1999
Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cellsI Delrieu, J C Faye, F Bayard, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|March 26, 1979
[Molecular forms of human leukocytic alpha-galactosidase and N-acetyl-alpha-galactosaminidase]R Salvayre, A Maret, A Nègre, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1980
[Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease]A Maret, R Salvayre, A Nègre, et al.
European Journal of Biochemistry|April 1, 1981
[Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)]A Maret, R Salvayre, A Negre, et al.
FEBS Letters|August 22, 1983
Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher diseaseA Maret, M Potier, R Salvayre, et al.
Cancer Research|January 19, 1999
Cell transformation results in the loss of the density-dependent translational regulation of the expression of fibroblast growth factor 2 isoformsB Galy, A Maret, A C Prats, et al.
European Journal of Biochemistry|February 15, 1985
[Neutral glycosphingolipids of Fabry's disease lymphoblastoid lines established by Epstein-Barr virus transformation]R Salvayre, A Maret, A Negre, et al.
The International Journal of Biochemistry|January 1, 1988
Mechanism of inhibition of beta-hexosaminidase B from human liver by short- and medium-chain monocarboxylic acidsM Hardy, R Salvayre, A Maret, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Biochemistry|June 15, 1983
Substrate specificity of the human splenic non-specific soluble beta-glucosidaseA Maret, R Salvayre, A Negre, et al.
Progress in Clinical and Biological Research|January 1, 1982
Comparative properties of the three groups of splenic beta-glucosidase molecular formsR Salvayre, A Maret, A Negre, et al.
The Biochemical Journal|May 7, 1999
Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cellsI Delrieu, J C Faye, F Bayard, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|March 26, 1979
[Molecular forms of human leukocytic alpha-galactosidase and N-acetyl-alpha-galactosaminidase]R Salvayre, A Maret, A Nègre, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1980
[Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease]A Maret, R Salvayre, A Nègre, et al.
European Journal of Biochemistry|April 1, 1981
[Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)]A Maret, R Salvayre, A Negre, et al.
FEBS Letters|August 22, 1983
Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher diseaseA Maret, M Potier, R Salvayre, et al.
Cancer Research|January 19, 1999
Cell transformation results in the loss of the density-dependent translational regulation of the expression of fibroblast growth factor 2 isoformsB Galy, A Maret, A C Prats, et al.
European Journal of Biochemistry|February 15, 1985
[Neutral glycosphingolipids of Fabry's disease lymphoblastoid lines established by Epstein-Barr virus transformation]R Salvayre, A Maret, A Negre, et al.
The International Journal of Biochemistry|January 1, 1988
Mechanism of inhibition of beta-hexosaminidase B from human liver by short- and medium-chain monocarboxylic acidsM Hardy, R Salvayre, A Maret, et al.
Pageof 8